BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32459985)

  • 1. How IGF-II Binds to the Human Type 1 Insulin-like Growth Factor Receptor.
    Xu Y; Kirk NS; Venugopal H; Margetts MB; Croll TI; Sandow JJ; Webb AI; Delaine CA; Forbes BE; Lawrence MC
    Structure; 2020 Jul; 28(7):786-798.e6. PubMed ID: 32459985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors.
    Surinya KH; Forbes BE; Occhiodoro F; Booker GW; Francis GL; Siddle K; Wallace JC; Cosgrove LJ
    J Biol Chem; 2008 Feb; 283(9):5355-63. PubMed ID: 18056713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.
    Alvino CL; McNeil KA; Ong SC; Delaine C; Booker GW; Wallace JC; Whittaker J; Forbes BE
    J Biol Chem; 2009 Mar; 284(12):7656-64. PubMed ID: 19139090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.
    Alvino CL; Ong SC; McNeil KA; Delaine C; Booker GW; Wallace JC; Forbes BE
    PLoS One; 2011; 6(11):e27488. PubMed ID: 22140443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor.
    Xu Y; Margetts MB; Venugopal H; Menting JG; Kirk NS; Croll TI; Delaine C; Forbes BE; Lawrence MC
    Structure; 2022 Aug; 30(8):1098-1108.e6. PubMed ID: 35660159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of Ligand-Bound Ectodomain Assembly in the Full-Length Human IGF-1 Receptor by Cryo-EM Single-Particle Analysis.
    Zhang X; Yu D; Sun J; Wu Y; Gong J; Li X; Liu L; Liu S; Liu J; Wu Y; Li D; Ma Y; Han X; Zhu Y; Wu Z; Wang Y; Ouyang Q; Wang T
    Structure; 2020 May; 28(5):555-561.e4. PubMed ID: 32275863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain.
    Hexnerová R; Křížková K; Fábry M; Sieglová I; Kedrová K; Collinsová M; Ullrichová P; Srb P; Williams C; Crump MP; Tošner Z; Jiráček J; Veverka V; Žáková L
    J Biol Chem; 2016 Sep; 291(40):21234-21245. PubMed ID: 27510031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
    Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
    J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?
    Blakesley VA; Scrimgeour A; Esposito D; Le Roith D
    Cytokine Growth Factor Rev; 1996 Aug; 7(2):153-9. PubMed ID: 8899293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.
    Forbes BE
    Pediatr Endocrinol Rev; 2011 Jun; 8(4):374-81. PubMed ID: 21972777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.
    Doern A; Cao X; Sereno A; Reyes CL; Altshuler A; Huang F; Hession C; Flavier A; Favis M; Tran H; Ailor E; Levesque M; Murphy T; Berquist L; Tamraz S; Snipas T; Garber E; Shestowsky WS; Rennard R; Graff CP; Wu X; Snyder W; Cole L; Gregson D; Shields M; Ho SN; Reff ME; Glaser SM; Dong J; Demarest SJ; Hariharan K
    J Biol Chem; 2009 Apr; 284(15):10254-67. PubMed ID: 19211557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
    Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
    PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent IGF-II analogues for FRET-based investigations into the binding of IGF-II to the IGF-1R.
    Cottam Jones JM; Harris PW; Scanlon DB; Forbes BE; Brimble MA; Abell AD
    Org Biomol Chem; 2016 Mar; 14(9):2698-705. PubMed ID: 26839188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity.
    Dong J; Sereno A; Aivazian D; Langley E; Miller BR; Snyder WB; Chan E; Cantele M; Morena R; Joseph IB; Boccia A; Virata C; Gamez J; Yco G; Favis M; Wu X; Graff CP; Wang Q; Rohde E; Rennard R; Berquist L; Huang F; Zhang Y; Gao SX; Ho SN; Demarest SJ; Reff ME; Hariharan K; Glaser SM
    MAbs; 2011; 3(3):273-88. PubMed ID: 21393993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Linked Glycosylation in Chinese Hamster Ovary Cells Is Critical for Insulin-like Growth Factor 1 Signaling.
    Salvi R; Kumar C; Brahmbhatt K; Subedi R; Idicula-Thomas S; Madan T; Biswas B
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise mapping of an IGF-I-binding site on the IGF-1R.
    Keyhanfar M; Booker GW; Whittaker J; Wallace JC; Forbes BE
    Biochem J; 2007 Jan; 401(1):269-77. PubMed ID: 16981855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards identification of a binding site on insulin-like growth factor-II for IGF-binding proteins.
    Bach LA; Hsieh S; Sakano K; Fujiwara H; Perdue JF; Rechler MM
    Adv Exp Med Biol; 1993; 343():55-61. PubMed ID: 7514352
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
    Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
    Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses.
    Macháčková K; Mlčochová K; Potalitsyn P; Hanková K; Socha O; Buděšínský M; Muždalo A; Lepšík M; Černeková M; Radosavljević J; Fábry M; Mitrová K; Chrudinová M; Lin J; Yurenko Y; Hobza P; Selicharová I; Žáková L; Jiráček J
    J Biol Chem; 2019 Nov; 294(46):17371-17382. PubMed ID: 31558604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
    Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
    Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.